# Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/osimertinib-for-pretreated-egfr-thr790met-positive-advanced-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Glenwood Goss,Chun‐Ming Tsai,Frances A. Shepherd,Lyudmila Bazhenova,Jong Seok Lee,Gee‐Chen Chang,Lucio Crinò,Miyako Satouchi,Quincy S. Chu,Toyoaki Hida,Ji‐Youn Han,Óscar Juan,Frank Dunphy,Makoto Nishio,Jin‐Hyoung Kang,Margarita Majem,Helen Mann,Mireille Cantarini,Serban Ghiorghiu,Tetsuya Mitsudomi |
| Citations | 648 |
| DOI | 10.1016/s1470-2045(16)30508-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2536396512 |
| PMID | 27751847 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Lyudmila Bazhenova](https://scholariq.org/researchers/lyudmila-bazhenova/)
- [Gee‐Chen Chang](https://scholariq.org/researchers/gee-chen-chang/)
- [Frances A. Shepherd](https://scholariq.org/researchers/frances-a-shepherd/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.